Current Medications
8 medications
Carbamazepine
Dose
300mg BID (600mg/day)
Timing
AM + PM
Purpose
Anticonvulsant
Class
Antiepileptic (sodium channel blocker)
Drug Level
7.77 (ref: 4-12)
CYP3A4 inducer
CYP3A4 inducer - reduces quetiapine & donepezil levels. Likely causing neutropenia (ANC 0.7). Level: 7.77 (therapeutic 4-12). Causing SIADH (osm 279).
Levetiracetam
Dose
500mg BID (1000mg/day)
Timing
AM + PM
Purpose
Anticonvulsant
Class
Antiepileptic (SV2A binding)
Keppra Rage - possible cause of screaming/irritability (~13% of adults). Level NEVER checked. Add B6 50-100mg. Risk factors: TBI with frontal involvement, pre-existing disinhibition.
Valproic Acid / Sodium Valproate
Dose
250mg evening only (tapering to stop)
Timing
Evening
Purpose
Anticonvulsant (TAPERING → STOP)
Class
Antiepileptic (GABA enhancer)
Drug Level
23.1 (ref: 50-100)
Mildly boosts quetiapine levels
Per Prof. Hassan Hosny (07 Mar 2026): Reduce to 250mg evening only starting 17 Mar 2026 for 3 weeks, then STOP completely (by ~7 Apr 2026). Level 23.1 (sub-therapeutic). DO NOT CRUSH — prolonged-release formulation.
Quetiapine
Dose
25mg
Timing
Bedtime
Purpose
Mood/Sleep
Class
Atypical antipsychotic
CYP3A4 substrate - affected by CBZ
STOPPED per Prof. Hassan Hosny (07 Mar 2026). Was 25mg bedtime — sedative-only dose. Replaced by Escitalopram for mood.
Baclofen
Dose
7.5mg AM + 10mg PM (tapering to stop)
Timing
AM + PM
Purpose
Muscle relaxant (spasticity)
Class
GABA-B agonist (antispastic)
Per Prof. Hassan Hosny (07 Mar 2026) — Gradual taper starting 17 Mar 2026: • 17 Mar – 31 Mar: 7.5mg AM + 10mg PM • 31 Mar – 14 Apr: 5mg AM + 10mg PM • 14 Apr – 28 Apr: 2.5mg AM + 10mg PM • After 28 Apr: STOP completely Separate from whey protein by 1-2 hours (LAT1 transporter competition). DO NOT stop abruptly (risk of seizure — Feb 2024 incident).
Donepezil HCL
Dose
5mg (tapering to stop)
Timing
Morning
Purpose
Memory/Cognition
Class
Cholinesterase inhibitor
CYP3A4 substrate
Per Prof. Hassan Hosny (07 Mar 2026): Reduce to 5mg for 2 weeks (17 Mar – 31 Mar 2026), then STOP completely. Previously 10mg. CBZ reduces its level via CYP3A4 induction.
Rosuvastatin
Dose
10mg
Timing
Bedtime
Purpose
Cholesterol (LDL 101)
Class
HMG-CoA reductase inhibitor (statin)
LDL 101 (target <100). Creatine may protect against statin myopathy. Depletes CoQ10. SEPARATE from Mg by 2+ hours (54% absorption reduction).
Escitalopram
Dose
10mg
Timing
Morning
Purpose
Mood enhancement (SSRI)
Class
SSRI (Selective Serotonin Reuptake Inhibitor)
CYP2C19 substrate, minor CYP3A4
Started per Prof. Hassan Hosny (07 Mar 2026). SSRI for mood enhancement. Replaces quetiapine for mood/sleep support. Safe with current AEDs. Monitor for initial GI side effects (nausea) in first 1-2 weeks.